Clinical implications of interleukins-31, 32, and 33 in gastric cancer

Table 3 Univariate and multivariate analyses of clinicopathological factors affecting survival of patients with gastric cancer in TNM I-II stage

Variable	Univariate HR (95%CI)	P value	Multivariate HR (95%CI)	P value
IL-32 (low/high)	0.180 (0.024-1.370)	0.098
Tumour differentiation		0.947
Low (reference)	1
High	1.259 (0.258-6.133)	0.776
Moderate	0.964 (0.324-2.871)	0.947
Tumour invasion depth		0.546
T4 (reference)	1
T2	0.567 (0.059-5.491)	0.624
T3	1.460 (0.187-11.379)	0.718
Lymph node metastasis (no/yes)	0.307 (0.108-0.868)	0.026	0.490 (0.152-1.578)	0.232
Diameter (< 5/≥ 5, cm)	0.259 (0.092-731)	0.011	0.368 (0.112-1.165)	0.088
Female/male	0.522 (0.116-2.340)	0.396
Age (≤ 60/> 60)	0.562 (0.192-1.646)	0.293